Guochen Creatures

Guochen Creatures

Together with you to create the future

查看更多
Guochen Creatures

Guochen Creatures

Together with you to create the future

查看更多

OUR SERVICES

Hand in hand with you to create a healthy every day

Small Molecule Services

链接

Small Molecule Services

Small Molecule Services

Macromolecular Services

链接

Macromolecular Services

Macromolecular Services

In vitro ADME Screening Services

链接

In vitro ADME Screening Services

In vitro ADME Screening Services

Animal Experimental Services

链接

Animal Experimental Services

Animal Experimental Services

Daily Chemical Testing Service

链接

Daily Chemical Testing Service

Daily Chemical Testing Service

Guochen Biology Makes Science and Technology More Progressive

Committed to using biotechnology innovations to solve multiple health challenges facing animals


Suzhou Guochen Biotechnology Co., Ltd. is located in Suzhou, China's biomedical innovation center known as "Paradise on Earth". It is committed to creating the future of medicine and building a high-end biomedical service outsourcing brand with excellent service quality. It focuses on providing professional clinical biological sample testing, preclinical pharmacokinetics and toxicology evaluation services to global customers.

Explore more
2016 +

Time of establishment

210 +

Core Team Members

5 +

Main business

1000 +

Testing experience

200 +

COOPERATION CUSTOMERS

system guarantee

Win-win cooperation, welcome new and old customers to consult and negotiate

Quality Assurance

Quality Assurance

Specification for quality management of drug clinical trials

Organizational guarantee

Organizational guarantee

Standard for quality management of non-clinical drug research

Process assurance

Process assurance

Biological Sample Analysis for Drug Clinical Trials

Information Assurance

Information Assurance

Laboratory Management Guide

Technical support

Technical support

Standard Operating Procedures (SOPs)

This local medical device company's profit in the first quarter exceeded 3.1 billion! Mindray, Xinhua, and United Imaging ranked in the top three, while GE, Philips, and Siemens lost momentum

This local medical device company's profit in the first quarter exceeded 3.1 billion! Mindray, Xinhua, and United Imaging ranked in the top three, while GE, Philips, and Siemens lost momentum

General considerations for ADC clinical dose optimization

General considerations for ADC clinical dose optimization

$9 billion! Eli Lilly invests to expand telportipad production capacity

$9 billion! Eli Lilly invests to expand telportipad production capacity

China's King of Medicine vs. World's King of Medicine "Sales TOP List"

China's King of Medicine vs. World's King of Medicine "Sales TOP List"

The world's leading drug in 2023 is Merck's oncology antibody therapy Keytruda, with annual sales reaching US$25 billion, a year-on-year increase of nearly 20%.

News dynamics

Daiichi Sankyo's TROP2 ADC has been approved for market launch in the United States.

Roche China has been named a "Top Employer in China" for nine consecutive years, ranking in the top ten.

JPM2025 Concludes: Undercurrents Among Pharmaceutical Giants, China's Innovation "Involution"

Looking Ahead to 2025: Five Key Highlights of the Global Biopharmaceutical Industry

Innovative drug commercialization, how to grab the stock, seek incremental? 2024CHDC-Conference Glimpse

Focus on Cell Therapy Gene Therapy AstraZeneca continues to seek new cooperation opportunities in China